ÌÇÐÄÆƽâ°æ

Revenue change of the pharmaceuticals market in Indonesia in 2024, by segment

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Supplementary notes

Data were modeled for: Anti-coagulants, Anti-diabetes drugs, Anti-fibrinolytics drugs, Anti-hypertensive drugs, Anti-rheumatic drugs, Antiviral drugs, Bronchodilator drugs, Dermatological drugs, Immunosuppressants, Lipid-lowering agents, Multiple sclerosis drugs, Oncology drugs, Other pharmaceuticals, Sensory organs drugs, and Vaccines.

Citation formats

Revenue change of the pharmaceuticals market in Indonesia 2024, by segment

Published by ÌÇÐÄÆƽâ°æ Research Department, Oct 29, 2025
In the pharmaceuticals market in Indonesia in 2024, antiviral drugs recorded the strongest revenue growth at approximately percent. The immunosuppressants segment followed with growth of around percent, while lipid-lowering agents ranked third with an estimated percent increase in revenue.

Log in or register to access precise data.
Use ÌÇÐÄÆƽâ°æ now: unlimited access to all content

Statistics on " Pharmaceutical industry in Indonesia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Indonesia

Overview

7

Manufacturing

6

OTC pharmaceuticals

7

Market players

4

International trade

6

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in IndonesiaHealth in IndonesiaTobacco industry in IndonesiaDemographics of IndonesiaMedical device industry in Indonesia
Use ÌÇÐÄÆƽâ°æ now: unlimited access to all content
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.